RxDoctor Payments Data

Stephanie Page

Pediatric Gastroenterology · Kansas City, MONPI 1679629299

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Regeneron at 53.1% of the total. Reporting peaked in 2024 at $4,049 and has fallen 87.3% since, to $514 in 2025.

$6,059in general payments, 2019–2025

Across 130 payments — averaging $46.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$3K
  • Regeneron Healthcare Solutions, Inc.$601
  • QOL Medical, LLC$548
  • Novo Nordisk$296
  • Tandem Diabetes Care, Inc.$247
  • Ascensia Diabetes Care US Inc.$213
  • plus $937 from 16 others

What the payments were for

  • Consulting fees$3,21653%
  • Food & beverage$2,82947%
  • Education$140%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,059 in reported general payments places this provider in the 85th percentile of 60 pediatric gastroenterology providers in Missouri.

See all pediatric gastroenterology providers in Missouri

Other pediatric gastroenterology in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →